Clinical trial
MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR): a Prospective, Multi-centre Cohort Observational Study- Presepsin (sCD14-ST) for Perioperative Risk Prediction Nested Cohort Study
NCT03489486 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR): a Prospective, Multi-centre Cohort Observational Study- Presepsin (sCD14-ST) for Perioperative Risk Prediction Nested Cohort Study
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 15, 2018
- Completion date
- April 30, 2019
- Enrollment
- 1,695 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non cardiac surgery